Home Cart Sign in  
Chemical Structure| 1910124-24-1 Chemical Structure| 1910124-24-1

Structure of GSK6853
CAS No.: 1910124-24-1

Chemical Structure| 1910124-24-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GSK6853 is a potent and selective inhibitor of RPF1 acetyl lysine (pKd=9.5), with 1600-fold selectivity over other acetyl lysines.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GSK6853

CAS No. :1910124-24-1
Formula : C22H27N5O3
M.W : 409.48
SMILES Code : O=C(NC1=C(N2[C@H](C)CNCC2)C=C(C(N3C)=C1)N(C)C3=O)C4=CC=CC=C4OC
MDL No. :MFCD30489734
InChI Key :FQWDVNSBYDXPIO-CQSZACIVSA-N
Pubchem ID :121232405

Safety of GSK6853

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GSK6853

epigenetics

Isoform Comparison

Biological Activity

Target
  • BRPF

    BRPF1, pIC50:8.1

In Vitro:

Cell Line
Concentration Treated Time Description References
OVCAR-3 10 µM and 20 µM 12 days To evaluate the effect of GSK6853 on ovarian cancer cell proliferation, results showed that GSK6853 significantly inhibited the proliferation of OVCAR-3 cells. PMC11880521
PEO4 10 µM and 20 µM 12 days To evaluate the effect of GSK6853 on ovarian cancer cell proliferation, results showed that GSK6853 significantly inhibited the proliferation of PEO4 cells. PMC11880521
Huh7 cells 32.9 ± 3.5 μM 72 h Induces cellular death without affecting cellular shape PMC11521936

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male CD1 mice Male CD1 mice Intraperitoneal (ip) 3 mg/kg Evaluated the suitability of GSK6853 for potential PK/PD models, showing that the ip route is suitable for dosing. PMC4904261

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.44mL

0.49mL

0.24mL

12.21mL

2.44mL

1.22mL

24.42mL

4.88mL

2.44mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories